Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of TAK-861, an Oral Orexin Receptor 2 Agonist, in Individuals with Narcolepsy Type 1: Results from a Phase 2 Trial and Long-Term Extension Study Interim Analysis

              Author:Dauvilliers, Yves   Mignot, Emmanuel   Plazzi, Giuseppe   Lammers, Gert Jan   Kadali, Harisha   Stukalin, Ellie   Hang, Yaming   Du, Yeting   Abraham, Anson   von Rosenstiel, Philipp   Tanaka, Shinichiro   Naylor, Melissa   Cai, Alice   Olsson, Tina   

              Session Name:P12: Sleep 4  

              Topic:Sleep  

              Program Number:P12.002  

              Author Institution:Hopital Gui De Chaulliac, Montpellier, France  Stanford Center for Sleep Sciences and Medicine, Redwood City, CA  University of Modena and Reggio-Emilia, Bologna, Italy  Leiden University Medical Centre, Leiden, Netherlands  Takeda Development Center Americas, Inc, Cambridge, MA